+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Polynucleotides Injectable Market Size, Share & Trends Analysis Report By Application (Eyes, Lips, Forehead, Jawline & Cheekbones), By End-use (MedSpas, Aesthetic & Cosmetic Centers), By Region, and Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 125 Pages
  • July 2024
  • Region: Global
  • Grand View Research
  • ID: 5990745
Description Jump to:
The global polynucleotides injectable market size was estimated at USD 111.5 million in 2023 and is projected to grow at a CAGR of 14.9% from 2024 to 2030.Technological advancements in biotechnology primarily drive the market, as do the growing demand for skin rejuvenation, personalized medicine, and investments in research and development (R&D). According to an article published by PMTA Journal in March 2024, polynucleotide injections gained prominence in aesthetic medicine due to their beneficial effects on skin, hair, and other tissues, as explored in this comprehensive review.

The growing demand for advanced skin rejuvenation treatments is a primary driver of the polynucleotides injectable market. As individuals seek more effective solutions to address signs of aging, such as fine lines, wrinkles, and skin laxity, the interest in novel injectable treatments such as polynucleotides has surged. For instance, a recent study published in the journal Dermatologic Therapy found that polynucleotide injections improved skin tone, fine lines, skin elasticity, and hydration in patients in their 30s and 40s.

The increasing focus on personalized medicine also contributed to the growth of the market. As healthcare providers and patients alike seek customized approaches to skin rejuvenation, polynucleotides' ability to stimulate the body's natural collagen production and cellular regeneration made them a popular choice. This trend is particularly evident in the rising demand for personalized aesthetic treatments, which is expected to continue expanding the market.

Finally, integrating innovative technologies, such as digital imaging and automated injection systems, has further propelled the polynucleotides injectables market. These advancements improved polynucleotide injections' precision, consistency, and safety, making them more appealing to healthcare providers and patients. As the aesthetic industry continues to evolve, incorporating cutting-edge technologies is expected to remain a vital driver of the polynucleotide injectable market. For instance, in 2022, Pulse Light Clinic in London is introducing PhilArt by Croma, an innovative polynucleotide injection treatment recognized for significantly enhancing skin hydration, boosting elasticity, and stimulating natural collagen production - a pioneering advancement in skin rejuvenation.

Global Polynucleotides Injectable Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, the publisher has segmented the global polynucleotides injectable market report based on application, end-use, and region.
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Eyes
  • Lips
  • Forehead
  • Jawline & Cheekbones
  • Others
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • MedSpas
  • Aesthetic & Cosmetic Centers
  • Hospitals
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Application
1.2.2. End Use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. Internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application outlook
2.2.2. End Use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Polynucleotides Injectable Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Technological advancements
3.2.1.2. Growing demand for skin rejuvenation
3.2.1.3. Shifting focus towards regenerative aesthetics
3.2.2. Market restraint analysis
3.2.2.1. Limited access to the treatments
3.3. Polynucleotides Injectable Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
Chapter 4. Polynucleotides Injectable Market: Application Estimates & Trend Analysis
4.1. Application Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Polynucleotides Injectable Market by Application Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Eyes
4.4.1.1. Eyes market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Lips
4.4.2.1. Lips market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Forehead
4.4.3.1. Forehead market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Jawline & Cheekbones
4.4.4.1. Jawline & Cheekbones market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. Others
4.4.5.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Polynucleotides Injectable Market: End Use Estimates & Trend Analysis
5.1. End Use Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Polynucleotides Injectable Market by End Use Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. MedSpas
5.4.1.1. MedSpas market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Aesthetic & Cosmetic Centers
5.4.2.1. Aesthetic & cosmetic centers market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Hospitals
5.4.3.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Polynucleotides Injectable Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
6.5. North America
6.5.1. North America
6.5.2. U.S.
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework
6.5.2.3. Competitive scenario
6.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
6.5.3. Canada
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework
6.5.3.3. Competitive scenario
6.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.5.4. Mexico
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework
6.5.4.3. Competitive scenario
6.5.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Europe
6.6.1. Europe
6.6.2. UK
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework
6.6.2.3. Competitive scenario
6.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
6.6.3. Germany
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework
6.6.3.3. Competitive scenario
6.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
6.6.4. France
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework
6.6.4.3. Competitive scenario
6.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
6.6.5. Italy
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework
6.6.5.3. Competitive scenario
6.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
6.6.6. Spain
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework
6.6.6.3. Competitive scenario
6.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
6.6.7. Denmark
6.6.7.1. Key country dynamics
6.6.7.2. Regulatory framework
6.6.7.3. Competitive scenario
6.6.7.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
6.6.8. Sweden
6.6.8.1. Key country dynamics
6.6.8.2. Regulatory framework
6.6.8.3. Competitive scenario
6.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
6.6.9. Norway
6.6.9.1. Key country dynamics
6.6.9.2. Regulatory framework
6.6.9.3. Competitive scenario
6.6.9.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Asia Pacific
6.7.1. Asia Pacific
6.7.2. Japan
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework
6.7.2.3. Competitive scenario
6.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
6.7.3. China
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework
6.7.3.3. Competitive scenario
6.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
6.7.4. India
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework
6.7.4.3. Competitive scenario
6.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
6.7.5. Australia
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework
6.7.5.3. Competitive scenario
6.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
6.7.6. South Korea
6.7.6.1. Key country dynamics
6.7.6.2. Regulatory framework
6.7.6.3. Competitive scenario
6.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
6.7.7. Thailand
6.7.7.1. Key country dynamics
6.7.7.2. Regulatory framework
6.7.7.3. Competitive scenario
6.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
6.8. Latin America
6.8.1. Latin America
6.8.2. Brazil
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework
6.8.2.3. Competitive scenario
6.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
6.8.3. Argentina
6.8.3.1. Key country dynamics
6.8.3.2. Regulatory framework
6.8.3.3. Competitive scenario
6.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
6.9. MEA
6.9.1. MEA
6.9.2. South Africa
6.9.2.1. Key country dynamics
6.9.2.2. Regulatory framework
6.9.2.3. Competitive scenario
6.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
6.9.3. Saudi Arabia
6.9.3.1. Key country dynamics
6.9.3.2. Regulatory framework
6.9.3.3. Competitive scenario
6.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
6.9.4. UAE
6.9.4.1. Key country dynamics
6.9.4.2. Regulatory framework
6.9.4.3. Competitive scenario
6.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
6.9.5. Kuwait
6.9.5.1. Key country dynamics
6.9.5.2. Regulatory framework
6.9.5.3. Competitive scenario
6.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2023
7.3.4. PHARMA RESEARCH
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Others benchmarking
7.3.4.4. Strategic initiatives
7.3.5. BIOPLUS CO., LTD.
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Others benchmarking
7.3.5.4. Strategic initiatives
7.3.6. LG Chem
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Others benchmarking
7.3.6.4. Strategic initiatives
7.3.7. AMEELA
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Others benchmarking
7.3.7.4. Strategic Initiatives
7.3.8. Mastelli
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Others benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Pluryal, Promoitalia Laboratories, Fox Pharma, BR Pharm, DermaFocus
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Others benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Promoitalia Laboratories
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Others benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Fox Pharma
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Others benchmarking
7.3.11.4. Strategic initiatives
7.3.12. BR Pharm
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Others benchmarking
7.3.12.4. Strategic initiatives
7.3.13. DermFocus
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. Others benchmarking
7.3.13.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 North America polynucleotides injectables market, by region, 2018 - 2030 (USD Million)
Table 3 North America polynucleotides injectables market, by application, 2018 - 2030 (USD Million)
Table 4 North America polynucleotides injectables market, by end use, 2018 - 2030 (USD Million)
Table 5 U.S. polynucleotides injectables market, by application, 2018 - 2030 (USD Million)
Table 6 U.S. polynucleotides injectables market, by end use, 2018 - 2030 (USD Million)
Table 7 Canada polynucleotides injectables market, by application, 2018 - 2030 (USD Million)
Table 8 Canada polynucleotides injectables market, by end use, 2018 - 2030 (USD Million)
Table 9 Mexico polynucleotides injectables market, by application, 2018 - 2030 (USD Million)
Table 10 Mexico polynucleotides injectables market, by end use, 2018 - 2030 (USD Million)
Table 11 Europe polynucleotides injectables market, by region, 2018 - 2030 (USD Million)
Table 12 Europe polynucleotides injectables market, by application, 2018 - 2030 (USD Million)
Table 13 Europe polynucleotides injectables market, by end use, 2018 - 2030 (USD Million)
Table 14 Germany polynucleotides injectables market, by application, 2018 - 2030 (USD Million)
Table 15 Germany polynucleotides injectables market, by end use, 2018 - 2030 (USD Million)
Table 16 UK polynucleotides injectables market, by application, 2018 - 2030 (USD Million)
Table 17 UK polynucleotides injectables market, by end use, 2018 - 2030 (USD Million)
Table 18 France polynucleotides injectables market, by application, 2018 - 2030 (USD Million)
Table 19 France polynucleotides injectables market, by end use, 2018 - 2030 (USD Million)
Table 20 Italy polynucleotides injectables market, by application, 2018 - 2030 (USD Million)
Table 21 Italy polynucleotides injectables market, by end use, 2018 - 2030 (USD Million)
Table 22 Spain polynucleotides injectables market, by application, 2018 - 2030 (USD Million)
Table 23 Spain polynucleotides injectables market, by end use, 2018 - 2030 (USD Million)
Table 24 Denmark polynucleotides injectables market, by application, 2018 - 2030 (USD Million)
Table 25 Denmark polynucleotides injectables market, by end use, 2018 - 2030 (USD Million)
Table 26 Sweden polynucleotides injectables market, by application, 2018 - 2030 (USD Million)
Table 27 Sweden polynucleotides injectables market, by end use, 2018 - 2030 (USD Million)
Table 28 Norway polynucleotides injectables market, by application, 2018 - 2030 (USD Million)
Table 29 Norway polynucleotides injectables market, by end use, 2018 - 2030 (USD Million)
Table 30 Asia Pacific polynucleotides injectables market, by region, 2018 - 2030 (USD Million)
Table 31 Asia Pacific polynucleotides injectables market, by application, 2018 - 2030 (USD Million)
Table 32 Asia Pacific polynucleotides injectables market, by end use, 2018 - 2030 (USD Million)
Table 33 China polynucleotides injectables market, by application, 2018 - 2030 (USD Million)
Table 34 China polynucleotides injectables market, by end use, 2018 - 2030 (USD Million)
Table 35 Japan polynucleotides injectables market, by application, 2018 - 2030 (USD Million)
Table 36 Japan polynucleotides injectables market, by end use, 2018 - 2030 (USD Million)
Table 37 India polynucleotides injectables market, by application, 2018 - 2030 (USD Million)
Table 38 India polynucleotides injectables market, by end use, 2018 - 2030 (USD Million)
Table 39 South Korea polynucleotides injectables market, by application, 2018 - 2030 (USD Million)
Table 40 South Korea polynucleotides injectables market, by end use, 2018 - 2030 (USD Million)
Table 41 Australia polynucleotides injectables market, by application, 2018 - 2030 (USD Million)
Table 42 Australia polynucleotides injectables market, by end use, 2018 - 2030 (USD Million)
Table 43 Thailand polynucleotides injectables market, by application, 2018 - 2030 (USD Million)
Table 44 Thailand polynucleotides injectables market, by end use, 2018 - 2030 (USD Million)
Table 45 Latin America polynucleotides injectables market, by application, 2018 - 2030 (USD Million)
Table 46 Latin America polynucleotides injectables market, by end use, 2018 - 2030 (USD Million)
Table 47 Brazil polynucleotides injectables market, by application, 2018 - 2030 (USD Million)
Table 48 Brazil polynucleotides injectables market, by end use, 2018 - 2030 (USD Million)
Table 49 Argentina polynucleotides injectables market, by application, 2018 - 2030 (USD Million)
Table 50 Argentina polynucleotides injectables market, by end use, 2018 - 2030 (USD Million)
Table 51 MEA polynucleotides injectables market, by region, 2018 - 2030 (USD Million)
Table 52 MEA polynucleotides injectables market, by application, 2018 - 2030 (USD Million)
Table 53 MEA polynucleotides injectables market, by end use, 2018 - 2030 (USD Million)
Table 54 South Africa polynucleotides injectables market, by application, 2018 - 2030 (USD Million)
Table 55 South Africa polynucleotides injectables market, by end use, 2018 - 2030 (USD Million)
Table 56 Saudi Arabia polynucleotides injectables market, by application, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia polynucleotides injectables market, by end use, 2018 - 2030 (USD Million)
Table 58 UAE polynucleotides injectables market, by application, 2018 - 2030 (USD Million)
Table 59 UAE polynucleotides injectables market, by end use, 2018 - 2030 (USD Million)
Table 60 Kuwait polynucleotides injectables market, by application, 2018 - 2030 (USD Million)
Table 61 Kuwait polynucleotides injectables market, by end use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Polynucleotides Injectable market: market outlook
Fig. 14 Polynucleotides Injectable competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Polynucleotides Injectable market driver impact
Fig. 20 Polynucleotides Injectable market restraint impact
Fig. 21 Polynucleotides Injectable market strategic initiatives analysis
Fig. 22 Polynucleotides Injectable market: application movement analysis
Fig. 23 Polynucleotides Injectable market: application outlook and key takeaways
Fig. 24 Eyes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Lips market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Forehead market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Jawline & cheekbones market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Polynucleotides Injectable market: end-use movement analysis
Fig. 30 Polynucleotides Injectable market: end-use outlook and key takeaways
Fig. 31 MedSpas market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Aesthetic & Cosmetic centers market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 33 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Global Polynucleotides Injectable market: Regional movement analysis
Fig. 35 Global Polynucleotides Injectable market: Regional outlook and key takeaways
Fig. 36 Global Polynucleotides Injectable market share and leading players
Fig. 37 North America market share and leading players
Fig. 38 Europe market share and leading players
Fig. 39 Asia Pacific market share and leading players
Fig. 40 Latin America market share and leading players
Fig. 41 Middle East & Africa market share and leading players
Fig. 42 North America, by country
Fig. 43 North America
Fig. 44 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 U.S. key country dynamics
Fig. 46 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Canada key country dynamics
Fig. 48 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Mexico key country dynamics
Fig. 50 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Europe
Fig. 52 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 UK key country dynamics
Fig. 54 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Germany key country dynamics
Fig. 56 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 France key country dynamics
Fig. 58 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Italy key country dynamics
Fig. 60 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Spain key country dynamics
Fig. 62 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Denmark key country dynamics
Fig. 64 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Sweden key country dynamics
Fig. 66 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Norway key country dynamics
Fig. 68 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Asia Pacific
Fig. 70 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 China key country dynamics
Fig. 72 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Japan key country dynamics
Fig. 74 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 India key country dynamics
Fig. 76 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Australia key country dynamics
Fig. 78 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 South Korea key country dynamics
Fig. 80 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Thailand key country dynamics
Fig. 82 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Latin America
Fig. 84 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Brazil key country dynamics
Fig. 86 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 87 Argentina key country dynamics
Fig. 88 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 89 Middle East and Africa
Fig. 90 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 91 South Africa key country dynamics
Fig. 92 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 93 Saudi Arabia key country dynamics
Fig. 94 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 UAE key country dynamics
Fig. 96 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 97 Kuwait key country dynamics
Fig. 98 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 99 Market share of key market players- Polynucleotides Injectable market

Companies Mentioned

  • PHARMA RESEARCH
  • BIOPLUS CO., LTD.
  • LG Chem
  • AMEELA
  • Mastelli
  • Pluryal
  • Promoitalia Laboratories.
  • Fox Pharma
  • BR Pharm
  • DermaFocus

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages125
PublishedJuly 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 111.5 Million
Forecasted Market Value ( USD ) by 2030 $ 293.4 Million
Compound Annual Growth Rate14.9%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Global Facial Injectable Market Size, Share & Trends Analysis Report by Product (Collagen & PMMA Microspheres, Hyaluronic Acid), Application (Facial Line Correction, Face Lift), End-use, Region, and Segment Forecasts, 2023-2030 - Product Image

Global Facial Injectable Market Size, Share & Trends Analysis Report by Product (Collagen & PMMA Microspheres, Hyaluronic Acid), Application (Facial Line Correction, Face Lift), End-use, Region, and Segment Forecasts, 2023-2030

  • Report
  • 172 Pages
  • Global
From
Global Osteoarthritis Injectables Market Size, Share & Trends Analysis Report by Injection Type (Hyaluronic Acid Injections, Corticosteroids Injections), Anatomy (Knee Osteoarthritis, Hip Osteoarthritis), End-use, and Segment Forecasts, 2024-2030 - Product Image

Global Osteoarthritis Injectables Market Size, Share & Trends Analysis Report by Injection Type (Hyaluronic Acid Injections, Corticosteroids Injections), Anatomy (Knee Osteoarthritis, Hip Osteoarthritis), End-use, and Segment Forecasts, 2024-2030

  • Report
  • 137 Pages
  • Global
From
Global Injectable Drug Delivery Market by Device Type (Conventional Injection Devices, Self-injection Devices), Usability (Disposable, Reusable), Therapeutic Application, End-user - Forecast 2024-2030 - Product Image

Global Injectable Drug Delivery Market by Device Type (Conventional Injection Devices, Self-injection Devices), Usability (Disposable, Reusable), Therapeutic Application, End-user - Forecast 2024-2030

  • Report
  • 190 Pages
  • Global
From
Global Aesthetic Injectables Market by Product (Anti-aging Injections, Dermal Fillers), Gender (Female, Male), Application, End User - Forecast 2024-2030 - Product Image

Global Aesthetic Injectables Market by Product (Anti-aging Injections, Dermal Fillers), Gender (Female, Male), Application, End User - Forecast 2024-2030

  • Report
  • 187 Pages
  • Global
From
Injectable Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Injectable Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.